We will serve some light refreshments from 09:30-10. The program will run from 10:00-12:00. Please sign up for the event here
Professor Bärnighausen holds positions at the University of Heidelberg and Harvard T.H Chan School of Public Health and is one of the most prominent global health scholars in Germany. In the seminar, he will present ongoing work on methods innovation in different strands of intervention research, including
- Population-based measurement of unmet healthcare need
- Research design to determine desirable and feasible models of delivery of health interventions
- Evaluation
- Policy translation
| Introduction | Andrea S. Winkler, Director of the Centre for Global Health and Professor at the Department of Community Medicine and Global Health |
| Key address | Till Bärnighausen, Alexander von Humboldt University Professor and Director of the Institute of Public Health at the Faculty of Medicine, University of Heidelberg, Germany and Adjunct Professor of Global Health at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health |
| Panel discussion |
Chair: Atle Fretheim, Director of Research and Innovation at the Division for Health Services, Norwegian Institute of Public Health, and Associate Professor at the Department of Community Medicine and Global Health, University of Oslo Panel:
|
About Professor Dr. Till Bärnighausen
Till Bärnighausen is Alexander von Humboldt University Professor and Director of the Institute of Public Health at the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at Harvard T.H. Chan School of Public Health; Faculty Member at the Harvard Center for Population and Development Studies; and Senior Faculty at the Wellcome Trust's Africa Health Research Institute in South Africa.
Till's research focuses on establishing the causal impact of global health interventions on population health, social and economic outcomes. In particular, he works on large-scale population health interventions for HIV, diabetes, hypertension, and vaccine-preventable diseases. His research has been funded by the Alexander von Humboldt Foundation, the Wellome Trust, NIH (including 6 R01 grants), the European Union, ANRS, International Initiative for Impact Evaluation (3ie), the Clinton Health Access Initiative (CHAI), the Elton John AIDS Foundation, the Rush Foundation, USAID, UNAIDS, World Bank, and GAVI. In 2016, Till received the Alexander von Humboldt Professor Award, Germany's most highly endowed international science price. Till has published more than 300 peer-reviewed articles, which have been cited more than 12,000. His h-index is 57 and his i10 index is 184.
Till was previously professor at the Harvard T.H. Chan School of Public Health and the University of KwaZulu-Natal. Till trained and worked as a medical doctor and clinical specialist in Family Medicine in Germany, China and South Africa. He also worked as a management consultant for McKinsey & Company and as a journalism trainee for Die Welt. Till holds doctoral degrees in International and Population Health (Harvard University) and History of Medicine (Heidelberg University), as well as master degrees in Health Systems Management (LSH&TM, University of London) and Financial Economics (SOAS, University of London)."